87. Pulmonary veno-occlusive disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 45
Pulmonary veno-occlusive disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 87 | Pulmonary veno-occlusive disease | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 4.000 |
| 34 | Neurofibromatosis | 4.000 |
| 85 | Idiopathic interstitial pneumonia | 4.000 |
| 86 | Pulmonary arterial hypertension | 4.000 |
| 89 | Lymphangioleiomyomatosis | 4.000 |
| 88 | Chronic thromboembolic pulmonary hypertension | 2.423 |
| 35 | Pemphigus | 2.352 |
| 162 | Pemphigoid | 2.318 |
| 28 | Systemic amyloidosis | 2.284 |
| 8 | Huntington disease | 2.277 |
| 51 | Scleroderma | 2.270 |
| 46 | Malignant rheumatoid arthritis | 2.262 |
| 6 | Parkinson disease | 2.262 |
| 227 | Osler disease | 1.087 |
| 2 | Amyotrophic lateral sclerosis | 1.012 |